Printer Friendly

BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS

     BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
    POMONA, N.Y., Nov. 12 /PRNewswire/ -- Barr Laboratories, Inc. (AMEX: BRL) has released financial results for the first quarter ended Sept. 30, 1991:
    Net sales in the first fiscal quarter of 1991 were $28,969,000 as compared to $18,785,000 for the comparable quarter last year, a 54 percent increase.  This represents the highest quarterly sales in the company's history.
    Net earnings for the quarter ended Sept. 30, 1991 were $1,047,000 or $.12 per share as compared to $348,000 or $.05 per share for the comparable quarter last year.  This represents an increase in net earnings of 201 percent over last year.
    The major reasons for the increase in sales and earnings are the increase in unit sales volume and an improved product mix which has yielded greater gross margins.
    Barr Laboratories is a prime manufacturer of a broad range of multi- source pharmaceutical products with manufacturing facilities located in both Northvale, N.J. and Pomona, N.Y.
               BARR LABORATORIES, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENT OF EARNINGS
       (Thousands of dollars except per share amounts, unaudited)
      Three months ended Sept. 30;               1991      1990
    Net sales                                  $28,969   $18,785
    Costs and expenses:
     Cost of sales                              18,995    12,961
     Distribution                                  941       699
     Marketing and sales                         1,850     1,189
     Research and development                    2,131     1,215
     General and administrative                  2,739     1,704
     Interest expense                              628       466
     Other (income)/expense, net                    22        (1)
     Earnings before income taxes                1,663       552
     Income tax provision                          616       204
     Net earnings                                1,047       348
     Net earnings per common
      share and common share
      equivalents                                 0.12        0.05
     Weighted average number
      of common share equivalents            8,649,313   7,606,982
    -0-          11/12/91
    /CONTACT:  Louis J. Guerci, vice president-finance of Barr Laboratories, 914-362-1100/
    (BRL) CO:  Barr Laboratories, Inc. ST:  New York IN:  MTC SU:  ERN FC-OS -- NY011 -- 3333 11/12/91 09:37 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 12, 1991
Words:322
Previous Article:HADSON REPORTS THIRD QUARTER RESULTS
Next Article:NCR UNVEILS NEW APPROACH TO SELF-SERVICE BANKING NEW ATMS THREE TIMES MORE RELIABLE THAN EXISTING NCR SYSTEMS (Product Announcement)
Topics:


Related Articles
BARR LABORATORIES RELEASES THIRD QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES SECOND QUARTER FINANCIAL RESULTS
BARR LABORATORIES RELEASES FIRST QUARTER FINANCIAL RESULTS
BARR LABORATORIES REPORTS RECORD RESULTS FOR FISCAL 1995; FOURTH QUARTER SALES CLIMB 37%; YEAR ENDS UP 83%
BARR LABORATORIES' FIRST QUARTER NET SALES CLIMB 23%; NET EARNINGS UP 19%
Barr Laboratories' Sales Climb 16% for Fiscal 1996; EPS Grows to $0.48 Record Revenues of $232 Million Reported
Barr Laboratories' Reports $0.12 Earnings Per Share For First Quarter 1997; Sales Climb 19% to $64 million
Barr Laboratories Reports Second Quarter EPS of $0.31 vs. $0.10 Last Year; Revenues Increase 37% to $92 Million; Net Earnings Climb 184% to $6 Million

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters